EXCLUSIVE: Co-Diagnostics Marks New Milestone as India TB Test Clinical Studies Begin
Co-Diagnostics Inc. (NASDAQ: CODX ) on Wednesday said CoSara Diagnostics Pvt. Ltd, its joint venture in India, is initiating clinical studies for the tuberculosis test on the CoSara PCR Pro instrument. The molecular diagnostics company said the initiation of these clinical studies marks another critical milestone for t